Total Payments
$23,762
2024 Payments
$4,937
Companies
37
Transactions
183
Medicare Patients
505
Medicare Billing
$102,865
Payment Breakdown by Category
Other$14,250 (60.0%)
Food & Beverage$8,405 (35.4%)
Consulting$900.00 (3.8%)
Education$207.29 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $14,250 | 5 | 60.0% |
| Food and Beverage | $8,405 | 174 | 35.4% |
| Consulting Fee | $900.00 | 1 | 3.8% |
| Education | $207.29 | 3 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Seagen Inc. | $11,378 | 18 | $0 (2023) |
| PFIZER INC. | $4,024 | 17 | $0 (2024) |
| Novocure Inc. | $2,097 | 28 | $0 (2024) |
| Monteris Medical Corporation | $1,251 | 13 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $1,149 | 5 | $0 (2022) |
| Amgen Inc. | $558.32 | 16 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $361.52 | 7 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $287.62 | 3 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $286.08 | 12 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $276.02 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,937 | 38 | PFIZER INC. ($3,583) |
| 2023 | $12,589 | 48 | Seagen Inc. ($11,235) |
| 2022 | $1,839 | 27 | Novocure Inc. ($479.17) |
| 2021 | $430.38 | 9 | Novocure Inc. ($323.29) |
| 2020 | $1,311 | 7 | Bayer HealthCare Pharmaceuticals Inc. ($928.42) |
| 2019 | $506.00 | 5 | Novocure Inc. ($385.18) |
| 2018 | $409.06 | 5 | Novocure Inc. ($292.95) |
| 2017 | $1,741 | 44 | Amgen Inc. ($453.70) |
All Payment Transactions
183 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Monteris Medical Corporation | Neuroblate (Device) | Food and Beverage | In-kind items and services | $96.40 | General |
| Category: Neuroblate | ||||||
| 12/03/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $29.26 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2024 | ARRAY BIOPHARMA INC | LORBRENA (Drug), BRAFTOVI, MEKTOVI | Food and Beverage | In-kind items and services | $1.27 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $25.89 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $9.29 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2024 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $16.54 | General |
| Category: Oncology | ||||||
| 10/31/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $32.00 | General |
| Category: Oncology | ||||||
| 10/24/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Oncology | ||||||
| 10/17/2024 | ABBVIE INC. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: ONCOLOGY | ||||||
| 10/10/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: ONCOLOGY | ||||||
| 09/25/2024 | Monteris Medical Corporation | Neuroblate (Device) | Food and Beverage | In-kind items and services | $99.98 | General |
| Category: Neuroblate | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $119.32 | General |
| Category: Oncology | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $34.07 | General |
| 09/12/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $33.81 | General |
| 09/10/2024 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Oncology | ||||||
| 08/26/2024 | ABBVIE INC. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: ONCOLOGY | ||||||
| 08/23/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $11.92 | General |
| Category: ONCOLOGY | ||||||
| 08/22/2024 | Monteris Medical Corporation | Neuroblate (Device) | Food and Beverage | In-kind items and services | $140.24 | General |
| Category: Neuroblate | ||||||
| 06/12/2024 | PFIZER INC. | TUKYSA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,420.00 | General |
| Category: Oncology | ||||||
| 06/12/2024 | PFIZER INC. | TUKYSA (Drug) | Food and Beverage | In-kind items and services | $90.88 | General |
| Category: Oncology | ||||||
| 06/05/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $10.05 | General |
| Category: ONCOLOGY | ||||||
| 05/10/2024 | Menarini Silicon Biosystems, Inc. | Cellsearch (Device) | Food and Beverage | Cash or cash equivalent | $68.13 | General |
| Category: Diagnostics | ||||||
| 05/02/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $135.03 | General |
| Category: ONC | ||||||
| 05/02/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $15.38 | General |
| Category: Oncology | ||||||
| 04/30/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.09 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 158 | 320 | $112,766 | $28,152 |
| 2022 | 4 | 110 | 207 | $51,097 | $18,748 |
| 2021 | 4 | 140 | 242 | $79,819 | $28,176 |
| 2020 | 2 | 97 | 266 | $99,380 | $27,789 |
Total Patients
505
Total Services
1,035
Medicare Billing
$102,865
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 31 | 78 | $32,058 | $8,048 | 25.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 24 | 77 | $26,334 | $6,584 | 25.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 38 | 79 | $22,120 | $5,692 | 25.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 28 | 34 | $16,932 | $4,193 | 24.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 14 | 14 | $7,266 | $1,895 | 26.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 11 | 23 | $5,221 | $1,063 | 20.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 15 | $2,835 | $676.91 | 23.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 32 | 74 | $17,056 | $8,326 | 48.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 17 | 33 | $8,882 | $2,587 | 29.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 22 | $8,894 | $2,506 | 28.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 17 | 27 | $3,852 | $2,099 | 54.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 20 | 27 | $7,865 | $2,059 | 26.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 13 | 24 | $4,548 | $1,171 | 25.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 44 | 122 | $48,447 | $16,763 | 34.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 64 | 85 | $22,042 | $8,543 | 38.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 16 | 16 | $8,684 | $2,722 | 31.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 16 | 19 | $646.00 | $147.63 | 22.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 53 | 183 | $74,308 | $20,753 | 27.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 44 | 83 | $25,072 | $7,036 | 28.1% |
About Dr. Amir Azadi, M.D
Dr. Amir Azadi, M.D is a Medical Oncology healthcare provider based in Phoenix, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2011. The National Provider Identifier (NPI) number assigned to this provider is 1154615607.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amir Azadi, M.D has received a total of $23,762 in payments from pharmaceutical and medical device companies, with $4,937 received in 2024. These payments were reported across 183 transactions from 37 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($14,250).
As a Medicare-enrolled provider, Azadi has provided services to 505 Medicare beneficiaries, totaling 1,035 services with total Medicare billing of $102,865. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical Oncology
- Location Phoenix, AZ
- Active Since 06/01/2011
- Last Updated 05/10/2023
- Taxonomy Code 207RX0202X
- Entity Type Individual
- NPI Number 1154615607
Products in Payments
- TUKYSA (Drug) $14,766
- Neuroblate (Device) $1,251
- Optune (Device) $1,223
- Vitrakvi (Drug) $1,133
- Oncology (Device) $854.52
- OPDIVO (Biological) $286.08
- SUTENT (Drug) $277.05
- DARZALEX (Biological) $245.77
- Vectibix (Biological) $218.97
- IBRANCE (Drug) $188.01
- Enhertu (Drug) $183.75
- ERLEADA (Drug) $157.21
- VENCLEXTA (Drug) $152.78
- ILLUCCIX (Drug) $141.24
- Trodelvy (Drug) $135.03
- ENHERTU (Biological) $119.32
- XGEVA (Biological) $118.55
- ANDEXXA (Biological) $115.90
- Nplate (Biological) $112.87
- IMFINZI (Drug) $109.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Oncology Doctors in Phoenix
Dr. Jason Salganick, Md, MD
Medical Oncology — Payments: $1.9M
Medical Oncology $1.9M
Mazen Khattab, Md, MD
Medical Oncology — Payments: $226,385
Medical Oncology $226,385
Panayiotis Savvides, Md, MD
Medical Oncology — Payments: $217,105
Medical Oncology $217,105
Amber Flaherty, M.d, M.D
Medical Oncology — Payments: $41,476
Medical Oncology $41,476
Tania Cortas, Md, MD
Medical Oncology — Payments: $36,718
Medical Oncology $36,718
Waqas Arslan, M.d, M.D
Medical Oncology — Payments: $34,523
Medical Oncology $34,523